G
G. Meininger
Researcher at Merck & Co.
Publications - 1
Citations - 673
G. Meininger is an academic researcher from Merck & Co.. The author has contributed to research in topics: Dipeptidyl peptidase-4 inhibitor & Sitagliptin. The author has an hindex of 1, co-authored 1 publications receiving 663 citations.
Papers
More filters
Journal ArticleDOI
Efficacy and safety of the dipeptidyl peptidase‐4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double‐blind, non‐inferiority trial
TL;DR: The primary aim is to compare the efficacy and safety of sitagliptin vs. glipizide in patients with type 2 diabetes and inadequate glycaemic control on metformin monotherapy.